灌输 发表于 2025-3-23 13:00:08

http://reply.papertrans.cn/71/7006/700579/700579_11.png

aristocracy 发表于 2025-3-23 14:58:31

Sohan Singh Hayreht dieser Substanz ausgerüstet werden, können sie künftig dasselbe tun wie ihr elterlicher Vorfahre, d. h. mit Hilfe von Zellen Nachkommen haben, die ihnen gleichen. Es muß also in jeder Vermehrungsrunde ebensoviel mehr von dieser Substanz gemacht werden, wie neue Teilchen entstehen sollen, und jede

strdulate 发表于 2025-3-23 18:14:43

http://reply.papertrans.cn/71/7006/700579/700579_13.png

高歌 发表于 2025-3-24 02:10:47

http://reply.papertrans.cn/71/7006/700579/700579_14.png

fastness 发表于 2025-3-24 04:29:17

Sohan Singh Hayrehr comprehensive knowledge and great experi­ ence which, after all, are necessary in respect of the classification of vis­ coelastic substances as therapeuticals on the one hand or medical devices on the other, and also to present these with expertise and to advise on the matter and to furnish a conc

Generosity 发表于 2025-3-24 06:44:56

Sohan Singh Hayrehr comprehensive knowledge and great experi­ ence which, after all, are necessary in respect of the classification of vis­ coelastic substances as therapeuticals on the one hand or medical devices on the other, and also to present these with expertise and to advise on the matter and to furnish a conc

我没有强迫 发表于 2025-3-24 12:05:28

http://reply.papertrans.cn/71/7006/700579/700579_17.png

Mutter 发表于 2025-3-24 18:32:27

http://reply.papertrans.cn/71/7006/700579/700579_18.png

悄悄移动 发表于 2025-3-24 22:24:14

http://reply.papertrans.cn/71/7006/700579/700579_19.png

RLS898 发表于 2025-3-25 02:52:00

The Ophthalmic Arterymens. A Medline search reveals that no further detailed, systematic anatomical study on a large number of specimens has followed mine, so that the following description is essentially based on my findings, with the addition of some later information.
页: 1 [2] 3 4 5 6
查看完整版本: Titlebook: Ocular Vascular Occlusive Disorders; Sohan Singh Hayreh Book 2015 Springer International Publishing Switzerland 2015 Hypertensive retinopa